Treating Rosacea

Expert Evaluation and Evidence-Based Management

Persistent facial redness that flares without warning, visible blood vessels creeping across your cheeks, or inflammatory bumps mistaken for adult acne. If any of this sounds familiar, you’re likely dealing with rosacea, and you’re far from alone. An estimated 16 million Americans live with this chronic skin condition, many of them undiagnosed or managing it incorrectly.

Rosacea is a long-term inflammatory skin disorder that primarily affects the face. It’s not contagious. It’s not caused by poor hygiene. But it is progressive when left untreated, and its impact extends well beyond the surface of your skin. Research consistently documents high rates of anxiety, embarrassment, and reduced quality of life among people with rosacea, with up to 75 percent reporting low self-esteem and more than 40 percent experiencing symptoms of anxiety.

At Connolly Dermatology, we provide expert evaluation and rosacea treatment guided by evidence-based care. Our board-certified dermatologists identify your specific rosacea subtype, pinpoint your personal trigger profile, and design a management plan that targets your symptoms with precision. From topical medications and oral therapy to laser and light-based treatments, we offer the full spectrum of evidence-supported interventions.

If redness, flushing, or skin changes on your face concern you, a dermatologic evaluation provides clarity and a path forward. Schedule an appointment with Connolly Dermatology and take control of your skin health today.

Understanding Rosacea

How Rosacea Differs From Acne and Other Facial Skin Conditions

Rosacea is a chronic, relapsing-remitting inflammatory disorder of the pilosebaceous unit and cutaneous vasculature. Its pathogenesis is multifactorial. Genetic susceptibility, dysregulated innate and adaptive immune responses, neurovascular hyperreactivity, and microbial factors all contribute to its development. No single cause has been isolated.

What sets rosacea apart is its pattern of involvement. It targets the central face in a characteristic distribution, the cheeks, nose, forehead, and chin, producing persistent erythema, telangiectasia, and in some subtypes, inflammatory papules and pustules. What it does not produce is comedones. The absence of blackheads and whiteheads is one of the most reliable clinical distinctions between rosacea and acne vulgaris.

Rosacea is classified into four principal subtypes based on predominant clinical features. Most patients present with features from more than one subtype, and the dominant presentation can shift over time. Understanding these subtypes is essential because each responds to different treatment strategies.

The Four Subtypes of Rosacea

Erythematotelangiectatic Rosacea (ETR): The most common subtype and often the first to appear. ETR is characterized by recurrent flushing, persistent central facial erythema, and visible telangiectasia (dilated blood vessels beneath the skin surface). Skin feels sensitive, often burning or stinging with temperature changes, wind, or skincare products. Without treatment, the background redness becomes permanent.

Papulopustular Rosacea (PPR): This subtype produces small erythematous papules and pustules across the central face, without the comedones that define acne. It’s sometimes called adult acne, a misleading label that leads to incorrect treatment. PPR responds well to topical and oral anti-inflammatory therapy and is often the most treatment-responsive subtype.

Phymatous Rosacea: A less common but visually striking subtype characterized by progressive thickening of the skin due to sebaceous gland hyperplasia and fibrosis. It most commonly affects the nose, producing the bulbous enlargement known as rhinophyma. Without intervention, phymatous changes are irreversible. Early medical treatment can slow progression and prevent surgical intervention.

Ocular Rosacea: Eye involvement occurs in more than 50 percent of rosacea patients and is frequently overlooked or attributed to allergies. Symptoms include chronic dryness, gritty or foreign-body sensation, tearing, burning, light sensitivity, and recurrent styes. In more severe cases, blepharitis and keratitis develop and can threaten long-term vision if left untreated.

Rosacea vs. Similar Facial Skin Conditions

Because rosacea shares features with several other conditions, accurate diagnosis is critical. The table below highlights the key distinguishing characteristics.

This table reflects common patterns, not universal rules. Many patients present with overlapping features. A board-certified dermatologist provides the definitive diagnosis when the clinical picture is unclear.

Is Rosacea Dangerous?

Rosacea is not life-threatening. It does not become cancerous. However, dismissing it as merely cosmetic understates its genuine consequences.

Untreated rosacea progresses. Persistent erythema becomes permanent. Telangiectasia accumulates. Phymatous subtypes cause disfiguring tissue changes that require surgical correction. Ocular rosacea, left unmanaged, can cause corneal scarring and permanent visual impairment. Beyond the skin, research has identified associations between rosacea and systemic conditions including cardiovascular disease, gastrointestinal disorders, neurological conditions, and autoimmune diseases, though these relationships are still being studied. What is established clearly is the profound psychosocial toll rosacea takes, with 88 percent of patients with severe disease reporting adverse effects on their professional interactions.

Signs and Symptoms of Rosacea

Rosacea presents differently in every patient, which is part of why it so often goes undiagnosed for years. Recognizing its full range of manifestations helps you identify the condition earlier and seek appropriate care before it progresses.

Flushing and Transient Erythema

The earliest and most universal symptom of rosacea is episodic flushing, a sudden wave of redness and warmth across the central face. Unlike the brief flush from embarrassment or physical exertion, rosacea flushing can last minutes to hours and recurs with increasing frequency over time. Hot beverages, spicy foods, alcohol, sun exposure, and temperature extremes are the most common provocateurs. Over years, repeated flushing episodes create a persistent background redness that no longer fully subsides between flares.

Persistent Facial Erythema

Persistent centrofacial redness is the hallmark finding of established rosacea. It follows a characteristic distribution across the cheeks, nose, chin, and forehead while typically sparing the periorbital area and nasolabial folds. This distribution is a key diagnostic feature that helps distinguish rosacea from lupus, which produces a similar butterfly pattern but characteristically spares the nasolabial folds. The redness in rosacea often appears disproportionate to how well the patient feels, and many patients describe decades of people asking if they’ve been in the sun.

Telangiectasia (Visible Blood Vessels)

As rosacea progresses, permanently dilated superficial blood vessels become visible through the skin, particularly across the cheeks and nose. These fine red or purple lines are called telangiectasia. They don’t resolve with topical skincare products and don’t respond to anti-inflammatory medications. Laser and light-based treatments are the most effective intervention for established telangiectasia.

Papules and Pustules

Papulopustular rosacea produces small, dome-shaped red papules and pus-filled pustules clustered across the central face. They closely resemble acne breakouts but lack the blackheads, whiteheads, and deep cysts that define acne vulgaris. They’re driven by inflammation rather than bacterial infection of blocked pores, which is why acne-targeted over-the-counter products are largely ineffective and sometimes irritating for rosacea-prone skin.

Skin Thickening and Phymatous Changes

In phymatous rosacea, sebaceous gland hyperplasia and dermal fibrosis cause progressive, irregular skin thickening. The nose is most commonly affected, developing the lobulated, bulbous appearance of rhinophyma. The chin, forehead, cheeks, and ears can also be involved. These changes begin as subtle textural shifts and, without treatment, advance to permanent cosmetic and functional deformity.

Ocular Symptoms

Rosacea affects the eyes in more than half of all patients, yet the skin and ocular symptoms don’t always appear together. Patients with minimal facial rosacea can have significant ocular involvement. Symptoms include chronic dryness, a persistent gritty or sandy sensation, excessive tearing, eyelid swelling or crusting, recurrent styes, sensitivity to light, and blurred vision. Blepharitis, the inflammation of the eyelid margin, is one of the most consistent ocular findings. Without treatment, ocular rosacea can progress to keratitis and corneal scarring.

Sensory Symptoms

Many patients experience burning, stinging, or itching on affected skin, even in areas that appear only mildly red. Skin feels persistently reactive, often becoming intolerant of products it previously tolerated. This heightened sensitivity reflects the underlying neurovascular dysregulation that drives rosacea’s pathophysiology.

Symptoms To Watch For

Rosacea is a progressive condition. Recognizing the early warning signs allows for intervention before permanent changes develop. See a dermatologist if you notice:

•         Recurrent facial flushing that lasts longer than a few minutes
•         Persistent redness across the central face that never fully clears
•         Visible blood vessels developing on the cheeks or nose
•         Papules or pustules on the face without comedones
•         Chronic eye irritation, dryness, styes, or eyelid inflammation
•         Thickening or irregular texture of the skin on the nose or cheeks
•         Burning or stinging with skincare products or temperature changes
•         Worsening symptoms despite avoidance of known triggers

Early evaluation and treatment slow rosacea’s progression and prevent the permanent vascular and structural changes that develop when the condition is left unmanaged.

Risk Factors for Developing Rosacea

Rosacea has no single identifiable cause. However, researchers have mapped out a clear set of predisposing factors that significantly elevate risk. Understanding them helps contextualize why the condition develops and informs how aggressively it should be managed.

Skin Type and Ethnicity

Fair skin is the strongest demographic risk factor for rosacea. The condition is most prevalent in individuals with Fitzpatrick skin phototypes I and II, those with very fair complexions that burn easily and rarely tan. People of Celtic, Irish, Scottish, English, and Northern European descent carry the highest population-level risk. Rosacea does occur in individuals with darker skin tones, but it is frequently underdiagnosed in these patients because the erythema is less visually apparent, delaying appropriate treatment.

Genetics and Family History

Twin studies estimate a 46 percent genetic contribution to rosacea development. Up to half of all rosacea patients report a family member with the condition. Researchers have identified three HLA alleles and specific single nucleotide polymorphisms associated with rosacea, several of which overlap with genetic markers for autoimmune conditions. If rosacea runs in your family, early dermatologic monitoring is worthwhile.

Age

Rosacea typically presents between the ages of 30 and 50, though it can develop earlier. Prevalence increases with age as cumulative UV exposure, vascular changes, and decades of immune dysregulation compound over time. The phymatous subtype tends to emerge later in life and progresses more slowly than inflammatory subtypes.

Sex

Rosacea affects both men and women, but with notable differences in distribution and severity. Women are more commonly diagnosed overall, likely because they seek dermatologic care at higher rates. However, men are significantly more likely to develop phymatous rosacea, particularly rhinophyma. Hormonal fluctuations during perimenopause also appear to trigger or worsen rosacea in women.

UV Radiation Exposure

Ultraviolet radiation is both the most common trigger for individual flares and a probable contributor to rosacea’s long-term progression. UV light activates toll-like receptor 2 on keratinocytes, stimulates the production of antimicrobial peptides including LL-37, and drives the vascular and inflammatory changes that define the condition. Patients who have spent years without consistent sun protection frequently present with more advanced disease.

Demodex Mite Colonization

Demodex folliculorum, a microscopic mite that normally inhabits human hair follicles in small numbers, is consistently found in higher densities on rosacea-affected skin. Whether this represents a cause or a consequence of rosacea’s inflammatory environment remains debated. What is established is that treating Demodex overgrowth with ivermectin produces measurable clinical improvement in papulopustular rosacea, suggesting a meaningful pathogenic role.

Immune System Dysregulation

Rosacea involves both innate and adaptive immune system dysfunction. Toll-like receptor 2 is overexpressed in rosacea-affected skin, driving excess production of the antimicrobial peptide cathelicidin LL-37. This peptide promotes vasodilation, angiogenesis, and leukocyte recruitment, perpetuating the inflammatory cycle. The dominant Th1 and Th17 adaptive immune responses further amplify tissue inflammation.

Can You Prevent Rosacea?

There is no proven method to prevent rosacea when genetic and immune predispositions are present. But identifying your personal trigger factors and managing them consistently is one of the most effective ways to reduce flare frequency and slow long-term progression.

Identify and Avoid Personal Triggers

Keep a symptom diary for 4 to 6 weeks, logging foods, beverages, activities, weather conditions, and skincare products alongside any rosacea flares. Common triggers include alcohol, hot beverages, spicy foods, UV exposure, extreme temperatures, exercise, and stress. Your trigger profile is personal and requires individual observation.

Commit to Daily Sun Protection

Broad-spectrum mineral sunscreen with SPF 30 or higher, applied every morning regardless of cloud cover, is one of the most impactful interventions for rosacea management. Physical sunscreens containing zinc oxide or titanium dioxide are generally better tolerated by rosacea-prone skin than chemical UV filters, which can be irritating.

Simplify and Protect Your Skin Barrier

Use a gentle, fragrance-free, pH-balanced cleanser twice daily. Apply a rosacea-appropriate moisturizer consistently to maintain barrier integrity. Avoid products containing alcohol, witch hazel, fragrances, menthol, peppermint, or eucalyptus oil, all of which are common irritants for sensitized rosacea skin.

Seek Regular Dermatologic Monitoring

Routine appointments allow your dermatologist to track disease progression, adjust treatment as your subtype or severity evolves, and intervene early before irreversible vascular or structural changes develop.

Diagnosis and Evaluation of Rosacea

Rosacea is a clinical diagnosis. No blood test confirms it. No imaging identifies it. An experienced dermatologist evaluates your skin directly, characterizes the subtype and severity of your presentation, screens for ocular involvement, and rules out conditions that mimic its appearance. That clinical evaluation is the foundation of every effective treatment plan.

Clinical Examination

Your dermatologist performs a thorough examination of your facial skin, assessing the distribution and character of erythema, the presence and extent of telangiectasia, any inflammatory papules or pustules, and early signs of phymatous change. The central facial pattern and absence of comedones are key diagnostic anchors. Your dermatologist also reviews your history of flushing episodes, duration of symptoms, and any skincare products or medications that worsen your skin.

Diagnostic Criteria

The current international standard, established by the National Rosacea Society Expert Committee and refined by the 2017 ROSCO panel, requires one of two diagnostic criteria for a confirmed rosacea diagnosis: persistent centrofacial erythema that periodically intensifies with trigger exposure, or phymatous changes. When neither criterion is met, two major features from a defined list, including flushing, inflammatory papulopustules, telangiectasia, or ocular manifestations, support the diagnosis.

Dermoscopy

Dermoscopy provides magnified visualization of vascular structures beneath the skin surface and is particularly valuable for characterizing telangiectasia patterns and distinguishing rosacea from other conditions. Under dermoscopy, rosacea typically shows a polygonal network of vessels in erythematotelangiectatic disease and follicular plugging in papulopustular presentations.

Ocular Screening

Because ocular rosacea affects more than half of all patients and frequently goes unrecognized, your dermatologist screens for ocular symptoms at every evaluation. Questions about chronic eye dryness, recurrent styes, eyelid crusting, gritty sensation, and light sensitivity are part of the standard rosacea assessment. Patients with moderate to severe ocular symptoms, or any visual disturbance, are referred to an ophthalmologist for co-management.

Hormonal and Laboratory Evaluation

In women whose rosacea worsens significantly with hormonal fluctuations, particularly around perimenopause or the menstrual cycle, or in patients with features suggesting concurrent conditions, targeted laboratory evaluation may be warranted. This is not routine for uncomplicated rosacea but helps identify contributing systemic factors in complex presentations.

Skin Biopsy

A biopsy is rarely needed for typical rosacea presentations. However, when the diagnosis is genuinely uncertain, when features suggest granulomatous rosacea, or when a more serious condition such as lupus cannot be excluded on clinical grounds alone, a small skin sample sent for histopathologic examination provides definitive information. The histologic features vary by subtype and confirm the diagnosis when clinical ambiguity persists.

When Should You Get Rosacea Evaluated?

You should see a dermatologist if you notice:

•         Persistent facial redness that does not resolve between flares
•         Recurrent flushing episodes triggered by heat, food, alcohol, or stress
•         Visible blood vessels developing on the cheeks, nose, or chin
•         Acne-like breakouts on the face without blackheads or whiteheads
•         Thickening or irregular texture of the nasal skin
•         Chronic eye dryness, irritation, or recurrent styes
•         Skin sensitivity that has increased over recent months or years
•         Any facial skin change that concerns you or affects your quality of life

Even mild rosacea warrants professional evaluation. A diagnosis provides clarity, confirms the subtype driving your symptoms, and opens access to treatments far more effective than anything available over the counter.

Rosacea Treatment Options

There is no cure for rosacea. The goal of treatment is to control symptoms, suppress flares, prevent progression, and improve quality of life over the long term. Because rosacea is a chronic condition with a relapsing-remitting course, management is ongoing, not a single course of treatment with a defined endpoint.

The most effective approach matches treatment to subtype. What works for persistent erythema does not address papulopustules. What reduces telangiectasia requires a different modality than what manages ocular involvement. Here is what the evidence supports for each clinical presentation.

Trigger Identification and Avoidance

Identifying and consistently avoiding personal triggers is the single highest-impact, lowest-risk intervention available for rosacea. Common triggers include UV light exposure, heat, hot beverages, alcohol (particularly red wine), spicy foods, extreme cold, vigorous exercise, emotional stress, certain skincare products, and some medications that cause vasodilation. Your trigger profile is individual. A symptom diary kept over 4 to 6 weeks is the most practical tool for identifying your specific patterns.

No medication or procedure fully compensates for persistent trigger exposure. Trigger management is not optional. It is the foundation of every rosacea treatment plan.

Gentle Skin Care and Sun Protection

Daily broad-spectrum mineral sunscreen with SPF 30 or higher is non-negotiable in rosacea management. UV radiation is rosacea’s most consistent trigger and one of its strongest long-term drivers. Physical sunscreens containing zinc oxide or titanium dioxide are preferred for rosacea-prone skin because they sit on top of the skin rather than being absorbed, reducing the risk of irritation.

Twice-daily cleansing with a gentle, fragrance-free, soap-free cleanser and consistent application of a rosacea-appropriate moisturizer supports the skin barrier and reduces reactivity. Rosacea-prone skin is hypersensitive by nature. An overly complex or aggressive skincare routine worsens symptoms.

Topical Medications for Erythema and Flushing

For patients with persistent facial erythema as a dominant feature, two FDA-approved topical vasoconstrictors offer targeted redness reduction.

Brimonidine tartrate 0.33% gel (Mirvaso) is a selective alpha-2 adrenergic receptor agonist that constricts superficial blood vessels, reducing erythema within 30 minutes of application. Its effects last up to 12 hours. High-quality clinical evidence from Cochrane reviews shows that 50 percent of patients achieve a two-grade improvement in erythema severity versus 20 percent with placebo. Its main limitations include rebound erythema in some patients and the need for consistent daily application.

Oxymetazoline hydrochloride 1% cream (Rhofade) works through a complementary alpha-1 adrenergic mechanism, similarly reducing erythema for up to 12 hours. Both agents are applied once daily and are FDA-approved for adults 18 and older.

Topical Medications for Papules and Pustules

Three topical agents have FDA approval and robust clinical evidence for papulopustular rosacea.

Ivermectin 1% cream (Soolantra) is applied once daily and addresses both the inflammatory and Demodex-related components of papulopustular rosacea. Multiple high-quality randomized controlled trials confirm it is slightly more effective than metronidazole, with excellent tolerability. It is a first-line choice for moderate papulopustular disease.

Metronidazole 0.75% to 1% gel or cream (MetroGel, MetroCream, Noritate) is applied once or twice daily and has decades of clinical evidence supporting its efficacy in reducing inflammatory lesions and erythema. It remains a widely used first-line option and an effective maintenance therapy.

Azelaic acid 15% gel (Finacea) is applied twice daily and offers anti-inflammatory and mild antimicrobial properties. Its additional benefit of reducing post-inflammatory hyperpigmentation makes it particularly valuable for patients with darker skin tones who are prone to pigmentation changes following rosacea flares.

Oral Antibiotics

When topical therapy alone fails to control papulopustular rosacea, or when disease is moderate to severe, oral antibiotics provide systemic anti-inflammatory benefit.

Low-dose doxycycline 40 mg once daily (Oracea), a modified-release formulation with both immediate and delayed-release components, is the only oral agent FDA-approved specifically for rosacea. At this sub-antimicrobial dose, it exerts meaningful anti-inflammatory effects without contributing to antibiotic resistance. High-quality clinical evidence from Cochrane reviews confirms its efficacy with fewer adverse effects than higher-dose doxycycline formulations.

Standard doxycycline 50 to 100 mg twice daily and minocycline 50 to 100 mg twice daily are also prescribed for inflammatory rosacea, typically for 8 to 12 weeks. Oral antibiotics are always combined with topical therapy and never used indefinitely. Once disease is controlled, topical maintenance therapy continues to prevent relapse.

Oral Isotretinoin

Low-dose oral isotretinoin at 0.25 to 0.3 mg per kilogram daily is a powerful option for severe papulopustular rosacea and early phymatous disease that has not responded to antibiotics. High-quality clinical evidence supports its superiority over doxycycline 50 to 100 mg for inflammatory rosacea. A treatment course typically runs 12 to 16 weeks.

Unlike in acne, rosacea commonly relapses after isotretinoin discontinuation, so maintenance topical therapy is essential following the completion of a course. Isotretinoin carries significant side effects and requires careful monitoring, including baseline and periodic blood work and, for women of childbearing age, mandatory pregnancy prevention through the iPLEDGE program.

Laser and Light-Based Treatments

For established telangiectasia and persistent erythema that does not respond to topical vasoconstrictors, laser and light-based therapies are the most effective available interventions.

Pulsed dye laser (PDL) at 585 to 595 nanometers and intense pulsed light (IPL) therapy both target oxyhemoglobin in dilated blood vessels, selectively destroying abnormal vasculature while leaving surrounding tissue intact. Cochrane review evidence confirms that both modalities produce meaningful improvement in erythema and telangiectasia with comparable efficacy. Multiple sessions are typically required, spaced 4 to 6 weeks apart.

IPL also addresses diffuse redness with a broader treatment area, making it particularly suited to widespread erythematotelangiectatic presentations. For ocular rosacea, IPL performed by an experienced practitioner offers additional benefit for meibomian gland dysfunction and chronic dry eye associated with the condition.

Treating Phymatous Rosacea

Medical therapy addresses early phymatous disease. Low-dose doxycycline slows sebaceous gland hyperplasia, and low-dose isotretinoin reduces sebaceous gland size, potentially preventing further thickening. Neither agent, however, reverses existing tissue hypertrophy.

Established rhinophyma and other phymatous changes require procedural intervention. Ablative CO2 laser is the most widely used and evidence-supported modality for surgical debulking of rhinophyma, offering precise tissue removal with controlled depth and good cosmetic outcomes. Erbium laser, electrosurgery, radiofrequency ablation, and scalpel excision are alternative approaches. The choice depends on the degree of tissue involvement and the treating physician’s experience.

Managing Ocular Rosacea

Ocular rosacea requires a structured, stepwise approach. Mild disease responds to warm compresses applied twice daily, gentle eyelid hygiene, omega-3 fatty acid supplementation, and preservative-free artificial tears. These measures address meibomian gland dysfunction and reduce eyelid inflammation.

Moderate to severe ocular rosacea requires medical therapy. Topical cyclosporine 0.05% ophthalmic emulsion (Restasis) reduces inflammatory mediators in the tear film and is more effective than artificial tears alone for burning and light sensitivity. Low-dose doxycycline or oral antibiotics address the systemic inflammatory component driving eyelid and conjunctival disease. Patients with visual disturbance or significant corneal involvement are co-managed with an ophthalmologist.

Maintenance Treatment

Because rosacea is a chronic relapsing condition, maintenance therapy is not optional. Once symptoms are controlled, stepping down to a simplified maintenance regimen, typically a single topical agent combined with ongoing trigger avoidance and sun protection, sustains remission and prolongs the interval between flares. Discontinuing all treatment after a good response almost invariably leads to recurrence.

Why Choose Connolly Dermatology for Rosacea Treatment

Care Guided by Experience and Clinical Judgment

Rosacea is a lifelong condition. Managing it well requires more than a single prescription. It requires accurate subtype identification, a treatment plan matched to your specific clinical features, consistent monitoring for progression, and the expertise to escalate therapy appropriately when first-line measures fall short. Connolly Dermatology provides that level of physician-led, evidence-guided care for every rosacea patient.

Board-Certified Dermatologists

Our dermatologists are trained in the full spectrum of rosacea presentations, from mild erythematotelangiectatic disease to advanced phymatous changes and complex ocular involvement. Every recommendation follows current clinical evidence and the most up-to-date guidelines from the American Academy of Dermatology and the National Rosacea Society.

Subtype-Specific Treatment Plans

We don’t apply a generic rosacea protocol to every patient. We identify your predominant subtype or combination of subtypes and design a targeted plan that addresses your specific features. The treatment approach for erythematotelangiectatic rosacea differs fundamentally from the approach for papulopustular or phymatous disease. Getting that distinction right from the start determines how quickly and effectively your symptoms are controlled.

Advanced Laser and Light-Based Treatments

For patients with established telangiectasia, persistent erythema, or rhinophyma, we offer pulsed dye laser, intense pulsed light, and ablative laser therapy. These treatments address the vascular and structural components of rosacea that medications cannot reverse. Our team has the experience to deliver these interventions safely and effectively across all skin types.

Ocular Rosacea Expertise and Coordination

Because more than half of rosacea patients have ocular involvement, we screen every patient and manage mild to moderate ocular disease within our practice. When symptoms are severe or visual function is at risk, we coordinate referral to trusted ophthalmology colleagues to ensure comprehensive co-management.

Honest Communication About Outcomes

Rosacea cannot be cured. We tell every patient that clearly from the start. What effective treatment achieves is meaningful, sustained symptom control that allows you to live without constant concern about flares. We set realistic expectations, discuss maintenance requirements honestly, and help you build a long-term management strategy rather than a short-term fix.

Patient Education and Support

Understanding your specific triggers, the rationale behind each element of your treatment plan, and the signs that indicate your rosacea is progressing empowers you to manage your condition far more effectively between appointments. We prioritize clear, practical patient education at every visit.

Comfortable, Compassionate Care

The psychosocial burden of rosacea is real and well-documented. Our team approaches every consultation with the sensitivity that a condition affecting your appearance, your confidence, and your daily life deserves.

What To Expect During Treatment

Guiding You Through Evaluation and the Next Steps

Starting rosacea care with a dermatologist, particularly if you’ve been managing on your own for years, can feel like a significant step. At Connolly Dermatology, we guide you through every stage of your evaluation and treatment so you understand exactly what’s happening and what to expect as your skin responds.

Before Your Appointment

Preparation helps your dermatologist build a complete picture quickly. Note when your symptoms first appeared and how they’ve changed over time. Record your current skincare routine, including every product you use on your face, and any medications you take. Identify any patterns you’ve already noticed between specific foods, activities, or conditions and your flares. This information shapes your initial evaluation and treatment plan from the very first visit.

During the Evaluation

Your dermatologist reviews your medical and skincare history, then performs a focused skin examination. They assess the distribution and character of your erythema, the presence of telangiectasia, papules, or pustules, and any early signs of phymatous changes. Dermoscopy may be used to visualize vascular structures more clearly. Your dermatologist also asks specifically about ocular symptoms to screen for rosacea involvement of the eyes.

Your dermatologist explains their findings clearly, identifies your subtype or combination of subtypes, and discusses your treatment options in plain language. Every recommendation is grounded in evidence and matched to what your skin actually presents. You’ll leave the consultation knowing exactly what you’re using, why you’re using it, and what results to expect.

When in-office procedures such as laser or light-based treatment are appropriate, these can often be scheduled promptly. For most patients beginning medical therapy, treatment starts with a prescription that day.

After Your First Visit

Most topical rosacea treatments require 4 to 12 weeks of consistent use before meaningful improvement becomes visible. Oral antibiotics typically show results within 8 to 12 weeks. Laser and light-based treatments produce progressive improvement over multiple sessions. Patience and consistency are essential, and we set these expectations honestly from the start.

Follow-up appointments are scheduled to evaluate your treatment response, assess for any side effects, and make adjustments as needed. If your initial treatment provides insufficient control, your dermatologist modifies the plan rather than repeating an ineffective approach.

Once your rosacea is well controlled, a maintenance plan is established to sustain remission. This typically involves a simplified topical regimen, ongoing sun protection, and continued trigger avoidance. Routine monitoring appointments remain valuable for catching early signs of progression and adjusting your plan as your skin’s needs evolve over time.

Get Clear Answers from Connolly Dermatology

Make Informed Decisions About Your Skin Health

Rosacea is a chronic inflammatory skin condition with a characteristic central facial distribution, a relapsing-remitting course, and a meaningful impact on quality of life when left unmanaged. It has four distinct subtypes, each requiring targeted treatment approaches. And it is progressive, causing permanent vascular and structural changes when appropriate intervention is delayed.

Managing rosacea effectively requires accurate diagnosis, subtype-specific treatment, consistent trigger avoidance, long-term maintenance, and ongoing monitoring by an experienced dermatologist. It is not a condition that resolves on its own or responds reliably to self-directed care.

If facial redness, flushing, visible blood vessels, acne-like breakouts without blackheads, or chronic eye irritation are affecting your daily life, a professional evaluation provides the clarity you need and opens access to treatments that genuinely work. At Connolly Dermatology, our board-certified dermatologists offer expert assessment and personalized, evidence-based care for every rosacea patient.

Schedule a visit with a dermatologist to get clear, informed guidance about your skin.